Anticancer agent 76
Anticancer agent 76 (Compound CT2-3) is an anticancer agent. Anticancer agent 76 significantly inhibits the proliferation of human NSCLC cells, induces cell cycle arrest, causes ROS generation and induces cell apoptosis[1].
Product Specifications
CAS Number
2448091-11-8
UNSPSC
12352005
Target
Apoptosis; c-Myc; ROS Kinase; Topoisomerase
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-76.html
Solubility
10 mM in DMSO
Smiles
O=C1N(CCCCS(CCOC2=CC=C(CC=C)C=C2C3=CC(CC=C)=CC=C3O)=O)C(C4=C1C=CC=C4)=O
Molecular Formula
C32H33NO5S
Molecular Weight
543.67
References & Citations
[1]Chen J, et al. CT2-3, a novel magnolol analogue suppresses NSCLC cells through triggering cell cycle arrest and apoptosis. Bioorg Med Chem. 2020 Mar 15;28 (6) :115352.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
